Aventamed 20product 20new4
Aventamed 20master 20logo


A new standard of care in ear tube surgery

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Cork, Ireland
  • Currency EUR
  • Founded August 2013
  • Employees 6
  • Incorporation Type Other
  • Website aventamed.com

Company Summary

The insertion of ear tubes to treat infections and hearing loss, is the number one reason why children undergo surgery in an operating room.With 2 million procedures annually, the global market is worth over $5 billion. AventaMed’s Solo Tympanostomy Tube Device(TTD), gives parents and surgeons the choice to undergo this surgery without general anaesthetic or a trip to the operating room.The total addressable market for the Solo TTD is $1bn.


  • Olive is a biomedical engineer with 18 years’ experience in the medical device and pharmaceutical industry. She has worked in multi-national and start-up companies in business, clinical and regulatory roles in the areas of oncology, cardiovascular and orthopedics. Olive has led international clinical trials with more than 15,000 patients in 200 countries, with subsequent EU and USA clearances.

  • John has over 15 years of experience in the medical device industry and has worked for numerous large medical device companies such as Stryker and Guidant. He is most experienced in medical device product development, strategic regulatory planning, regulatory approval, IP development and product realization. He has invented, designed and commercially launched numerous products worldwide. He is also an inventor on over 50 patents.

  • Aef0d11a 185d 4789 b499 23a9a682d363

    Jack brings significant experience to the Board of AventaMed. He has held senior positions in International business and a Board member for several companies in North America and Europe. He is now a Director of Telesat Holdings Inc. (Canada) and Mettrum Health Corp. ( Canada). He was Chairman of Vectura Plc taking it public on LSX and Chairman and joint-CEO of RP Scherer, taking it public on NYSE.

  • Default avatar
    Bernard Lim
    Non-executive Director

    Bernard is a senior international executive with a track record of innovation,exceptional performance improvements, change and growth in multiple industry sectors including medical devices,diagnostics, biotech, electronics and high technology across US, Canada, UK and Europe.He excels in strategic and operational leadership resulting in significant P&L, product development and operational performance within multinationals and start-up companies.